Quality of life impairment and psychological distress in elderly patients with psoriasis

Dermatology

Volumn 215, Issue 4, 2007, Pages 341-347

  Sampogna, F ^a   Tabolli, S ^a   Mastroeni, S ^a   Di Pietro, C ^a   Fortes, C ^a   Abeni, D ^a   Alotto, Massimo ^b   Antonelli, Gianluca ^b   Bolli, Simone ^b   Chinni, Massimo Luca ^b   Fazio, Marcello ^b   Girolomoni, Giampiero ^b   Luchetti, Elisabetta ^b   Mazzotti, Eva ^b   Salcedo, Nidia Melo ^b   Moscatelli, Paola ^b   Pasquini, Paolo ^b   Piazza, Paolo ^b   Picconi, Orietta ^b   Pilla, Maria Antonietta ^b   Primavera, Grazia ^b   Puddu, Pietro ^b   Ruatti, Paolo ^b   Ruggiero, Giuseppe ^b   Salvatori, Valentina ^b   Sera, Francesco ^b   Simoni, Romeo ^b   Sordi, Donatella ^b   Tiago, Albertina ^b   more..

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b Istituto Dermopatico dell'Immacolata IDI IRCCS ^*

Author keywords

Psoriasis, elderly; Psychosocial aspects, psoriasis; Quality of life

Indexed keywords

AGED; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DISTRESS SYNDROME; ELDERLY CARE; EMOTIONALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PSORIASIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 34948887188     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107628     Document Type: Article

References (39)

1. De Rie MA, Goedkoop AY, Bos JD: Overview of psoriasis. Dermatol Ther 2004;17:341-349.
2. Naldi L: Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:121-128.
3. Schafer T: Epidemiology of psoriasis: review and the German perspective. Dermatology 2006;212:327-337.
4. Gupta MA, Gupta AK: Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:241-242.
5. Fried RG, Friedman S, Paradis C, et al: Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995;34:101-105.
6. Finlay AY, Coles EC: The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-244.
7. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE: Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997;42:467-475.
8. Zachariae R, Zachariae H, Blomqvist K, et al: Quality of life in 6,497 Nordic patients with psoriasis. Br J Dermatol 2002;146:1006-1016.
9. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-284.
10. Choi J, Koo JY: Quality of life issues in psoriasis. J Am Acad Dermatol 2003;49:S57-S61.
11. Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D: Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol 2006;154:325-331.
12. Sampogna F, Gisondi P, Tabolli S, Abeni D: Impairment of sexual life in patients with psoriasis. Dermatology 2007;214:144-150.
13. Schmitt JM, Ford DE: Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006;213:102-110.
14. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S: An Italian study on psoriasis and depression. Dermatology 2006;212:123-127.
15. Jobling R: The patient's perspective; in Barker J, Griffiths C (eds): Key Advances in the Effective Management of Psoriasis. London, The Royal Society of Medicine Press, 1999, pp 9-12.
16. Hughes JE, Barraclough BM, Hamblin LG, White JE: Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51-54.
17. Gupta MA, Gupta AK: Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Ann NY Acad Sci 1999;885:394-395.
18. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P: Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983-991.
19. Sampogna F, Sera F, Abeni D: Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004;122:602-607.
20. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ: Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-1440.
21. Feldman SR, Fleischer AB Jr, Reboussin DM, et al: The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996;106:183-186.
22. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM: Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology 2002;204:43-49.
23. Bellantuono C, Fiorio R, Zanotelli R, Tansella M: Psychiatric screening in general practice in Italy: a validity study of the GHQ (General Health Questionnaire). Soc Psychiatry 1987;22:113-117.
24. Goldberg D: The Detection of Psychiatric Illness by Questionnaire. London: Oxford University Press, 1972.
25. Picardi A, Abeni D, Pasquini P: Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol 2001;15:410-417.
26. Sampogna F, Sera F, Mazzotti E, Pasquini P, Picardi A, Abeni D: Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003;139:353-358; discussion 357.
27. Picardi A, Abeni D, Mazzotti E, et al: Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire (GHQ-12). J Psychosom Res 2004;57:219-223.
28. Anonymous: The uses of epidemiology in the study of the elderly: report of a WHO Scientific Group on the Epidemiology of Aging. World Health Organ Tech Rep Ser 1984;706:1-84.
29. Norusis M: SPSS for Windows. Professional and Advanced Statistics, Release 9.0. Chicago, SPSS Inc, 1999.
30. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE: Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999;141:185-191.
31. Jayaprakasam A, Darvay A, Osborne G, McGibbon D: Comparison of assessments of severity and quality of life in cutaneous disease. Clin Exp Dermatol 2002;27:306-308.
32. Emery CF, Frid DJ, Engebretson TO, et al: Gender differences in quality of life among cardiac patients. Psychosom Med 2004;66:190-197.
33. Wallenhammar LM, Nyfjall M, Lindberg M, Meding B: Health-related quality of life and hand eczema - a comparison of two instruments, including factor analysis. J Invest Dermatol 2004;122:1381-1389.
34. Sheffield D, Biles PL, Orom H, Maixner W, Sheps DS: Race and sex differences in cutaneous pain perception. Psychosom Med 2000;62:517-523.
35. Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D: Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol 2004;151:594-599.
36. Picardi A, Abeni D, Renzi C, Braga M, Puddu P, Pasquini P: Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001;81:410-414.
37. Fortune DG, Richards HL, Kirby B, et al: Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003;139:752-756.
38. Renzi C, Picardi A, Abeni D, et al: Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002;138:337-342.
39. Agenzia Italiana del Farmaco: Psocare Study. http://www.psocare.it/en- index.php.